Shaofan Hu

667 total citations
31 papers, 382 citations indexed

About

Shaofan Hu is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Shaofan Hu has authored 31 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 6 papers in Cell Biology and 4 papers in Oncology. Recurrent topics in Shaofan Hu's work include Genomics, phytochemicals, and oxidative stress (20 papers), Glutathione Transferases and Polymorphisms (7 papers) and Endoplasmic Reticulum Stress and Disease (6 papers). Shaofan Hu is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (20 papers), Glutathione Transferases and Polymorphisms (7 papers) and Endoplasmic Reticulum Stress and Disease (6 papers). Shaofan Hu collaborates with scholars based in China, United Kingdom and United States. Shaofan Hu's co-authors include Yiguo Zhang, Zhengwen Zhang, Lu Qiu, Keli Liu, Meng Wang, Feilong Chen, Jing Feng, Yuancai Xiang, Meng Wang and Ze Zheng and has published in prestigious journals such as PLoS ONE, Free Radical Biology and Medicine and International Journal of Molecular Sciences.

In The Last Decade

Shaofan Hu

27 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shaofan Hu China 11 282 54 54 50 44 31 382
Marju Puurand Estonia 13 294 1.0× 30 0.6× 50 0.9× 85 1.7× 92 2.1× 25 453
Fang Du China 13 288 1.0× 68 1.3× 32 0.6× 85 1.7× 122 2.8× 25 557
Anna Sadowska Poland 11 203 0.7× 34 0.6× 28 0.5× 35 0.7× 84 1.9× 22 385
Di Lü China 13 337 1.2× 48 0.9× 16 0.3× 55 1.1× 28 0.6× 28 494
Jieyu Liu China 12 228 0.8× 39 0.7× 37 0.7× 60 1.2× 37 0.8× 51 465
Katherine L. Luo United States 6 163 0.6× 62 1.1× 111 2.1× 28 0.6× 33 0.8× 9 329
Xiangxia Luo United States 10 402 1.4× 48 0.9× 68 1.3× 33 0.7× 21 0.5× 22 517
Wan‐Yu Yang Taiwan 11 163 0.6× 54 1.0× 104 1.9× 73 1.5× 38 0.9× 17 379
Dhaval S. Patel United States 6 212 0.8× 47 0.9× 49 0.9× 28 0.6× 65 1.5× 8 365
Edgar Bernardo Spain 7 157 0.6× 62 1.1× 15 0.3× 38 0.8× 79 1.8× 8 290

Countries citing papers authored by Shaofan Hu

Since Specialization
Citations

This map shows the geographic impact of Shaofan Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaofan Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaofan Hu more than expected).

Fields of papers citing papers by Shaofan Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaofan Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaofan Hu. The network helps show where Shaofan Hu may publish in the future.

Co-authorship network of co-authors of Shaofan Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Shaofan Hu. A scholar is included among the top collaborators of Shaofan Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaofan Hu. Shaofan Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Keli, Shiqun Chen, Shaofan Hu, et al.. (2025). Inhibition of NFE2L1 Enables the Tumor‐Associated Macrophage Polarization and Enhances Anti‐PD1 Immunotherapy in Glioma. CNS Neuroscience & Therapeutics. 31(7). e70488–e70488.
2.
Chen, Feilong, Lei Lyu, Chengyuan Xing, et al.. (2025). The pivotal role of TGF-β/Smad pathway in fibrosis pathogenesis and treatment. Frontiers in Oncology. 15. 1649179–1649179.
3.
Hu, Shaofan, Hong Lee Heng, Fang Yang, et al.. (2025). The metabolism-immune axis in colorectal cancer: remodeling the tumor microenvironment through metabolite signaling. Frontiers in Immunology. 16. 1735873–1735873.
4.
Liu, Keli, Shaofan Hu, Lu Qiu, et al.. (2025). Deficiency of DDI2 suppresses liver cancer progression by worsening cell survival conditions. Free Radical Biology and Medicine. 232. 200–213.
5.
Wang, Meng, et al.. (2025). Deletion of Nrf1α exacerbates oxidative stress-induced cellular senescence by disrupting cell homeostasis. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1872(6). 119970–119970. 1 indexed citations
7.
Liu, Keli, Jing Feng, Meng Wang, et al.. (2024). Distinct mechanisms by which Nrf1 and Nrf2 as drug targets contribute to the anticancer efficacy of cisplatin on hepatoma cells. Free Radical Biology and Medicine. 213. 488–511. 6 indexed citations
8.
Zheng, Ze, Shaofan Hu, Jing Feng, et al.. (2023). Loss of Nrf1 rather than Nrf2 leads to inflammatory accumulation of lipids and reactive oxygen species in human hepatoma cells, which is alleviated by 2-bromopalmitate. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1871(2). 119644–119644. 7 indexed citations
9.
Wang, Qing, et al.. (2023). STC2 is a potential biomarker of hepatocellular carcinoma with its expression being upregulated in Nrf1α-deficient cells, but downregulated in Nrf2-deficient cells. International Journal of Biological Macromolecules. 253(Pt 8). 127575–127575. 4 indexed citations
10.
Hu, Shaofan, Hong Liu, Qun Li, et al.. (2022). Suppressing the activity of CXCR4 down-regulates the expression of renal fibrosis related genes in primary glomerular cells. Translational Pediatrics. 11(6). 882–890. 2 indexed citations
11.
Hu, Shaofan, Yuancai Xiang, Lu Qiu, Meng Wang, & Yiguo Zhang. (2022). Activation of the membrane-bound Nrf1 transcription factor by USP19, a ubiquitin-specific protease C-terminally anchored in the endoplasmic reticulum. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1869(9). 119299–119299. 9 indexed citations
12.
Feng, Jing, et al.. (2022). The Role of MicroRNA in the Regulation of Tumor Epithelial–Mesenchymal Transition. Cells. 11(13). 1981–1981. 25 indexed citations
13.
Hu, Shaofan, Jing Feng, Meng Wang, et al.. (2022). Nrf1 is an indispensable redox-determining factor for mitochondrial homeostasis by integrating multi-hierarchical regulatory networks. Redox Biology. 57. 102470–102470. 64 indexed citations
14.
Chen, Feilong, et al.. (2022). Different Inhibition of Nrf2 by Two Keap1 Isoforms α and β to Shape Malignant Behaviour of Human Hepatocellular Carcinoma. International Journal of Molecular Sciences. 23(18). 10342–10342. 10 indexed citations
15.
Wang, Meng, Yonggang Ren, Shaofan Hu, et al.. (2021). TCF11 Has a Potent Tumor-Repressing Effect Than Its Prototypic Nrf1α by Definition of Both Similar Yet Different Regulatory Profiles, With a Striking Disparity From Nrf2. Frontiers in Oncology. 11. 707032–707032. 7 indexed citations
17.
Xiang, Yuancai, Shaofan Hu, Meng Wang, et al.. (2018). Topovectorial mechanisms control the juxtamembrane proteolytic processing of Nrf1 to remove its N-terminal polypeptides during maturation of the CNC-bZIP factor. Toxicology and Applied Pharmacology. 360. 160–184. 16 indexed citations
18.
Xiang, Yuancai, Meng Wang, Shaofan Hu, et al.. (2018). Mechanisms controlling the multistage post-translational processing of endogenous Nrf1α/TCF11 proteins to yield distinct isoforms within the coupled positive and negative feedback circuits. Toxicology and Applied Pharmacology. 360. 212–235. 31 indexed citations
19.
Jiang, Zhi‐Dong, Ashley Alexander, Ke Shi, et al.. (2017). Stability and efficacy of frozen and lyophilized fecal microbiota transplant (FMT) product in a mouse model of Clostridium difficile infection (CDI). Anaerobe. 48. 110–114. 35 indexed citations
20.
Hu, Shaofan, Ke Shi, Ming Jiang, et al.. (2015). A Single Fas Gene Mutation Changes Lupus Onset, Severity, Location, and Molecular Abnormalities in Mice. Current Molecular Medicine. 15(4). 380–385. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026